Skip to search formSkip to main contentSkip to account menu

FK 037

Known as: FK-037, FK037 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1997
1997
The activity of methicillin, oxacillin, vancomycin, imipenem and FK037 against 106 isolates of staphylococci was assessed using a… 
1994
1994
A mathematical multiple dosing model was designed so that human plasma concentration-versus-time curves of beta-lactams are… 
1994
1994
A single 1-g or 2-g intravenous dose of the cephalosporin FK-037 was given over 30 min in a cross-over-designed study, to each of… 
1994
1994
The in-vitro activity of the parenteral cephem FK-037 was compared to those of cefpirome, ceftazidime, cefuroxime, cefixime… 
1993
1993
The in vitro activity of FK-037, 5-amino-2-[[(6R, 7R)-7-[[(Z)-2-(2-amino-4-thiazolyl)-2- methoxyimino) acetyl] amino]-2-carboxy-8… 
1993
1993
FK037 is a new parenteral cephalosporin, which offers some advantages over the commercially available parenteral cephalosporins… 
1993
1993
The activity of FK037, a new parenteral cephalosporin, was compared with those of cefpirome, ceftazidime, and flomoxef against… 
1993
1993
FK037 has potent therapeutic activity against lethal systemic infections and experimental local infections due to a wide variety…